首页> 外文期刊>Daru Journal of pharmaceutical sciences. >Pirfenidone; can it be a new horizon for the treatment of pulmonary fibrosis in mustard gas-intoxicated patients?
【24h】

Pirfenidone; can it be a new horizon for the treatment of pulmonary fibrosis in mustard gas-intoxicated patients?

机译:吡非尼酮;芥子气中毒患者的肺纤维化治疗是否有新的前景?

获取原文
           

摘要

Sulfur mustard is an alkylating substance still regarded as a threat in chemical warfare and terrorism. Lung parenchymal damage occurs in the most severe inhalational exposures. It accompanies an increased risk of respiratory tract carcinomas and chronic respiratory sequelae including chronic bronchitis, bronchiectasis, pulmonary fibrosis, interstitial lung disease, emphysema, and bronchiolitis obliterans. Pirfenidone is an antifibrotic with anti-inflammatory and anti hydroxyl radical activities which stabilizes pulmonary function in idiopathic pulmonary fibrosis patients. It can be suggested in chronically exposed soldiers or workers with signs and symptoms of pulmonary fibrosis to improve their quality of life and even prognosis.
机译:芥菜籽是一种烷基化物质,仍然被视为化学战和恐怖主义的威胁。肺实质损害发生在最严重的吸入暴露中。它伴随着呼吸道癌和慢性呼吸道后遗症的风险增加,包括慢性支气管炎,支气管扩张,肺纤维化,间质性肺病,肺气肿和闭塞性细支气管炎。吡非尼酮是一种具有抗炎和抗羟基自由基活性的抗纤维化药,可稳定特发性肺纤维化患者的肺功能。可以建议长期接触肺纤维化的体征和症状的士兵或工人,以改善其生活质量甚至预后。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号